SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-18-048731
Filing Date
2018-02-16
Accepted
2018-02-16 17:04:59
Documents
4
Period of Report
2018-02-15
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d541046d8k.htm 8-K 18259
2 EX-99.1 d541046dex991.htm EX-99.1 6343
3 GRAPHIC g541046g04z72.jpg GRAPHIC 2393
4 GRAPHIC g541046g96r83.jpg GRAPHIC 3252
  Complete submission text file 0001193125-18-048731.txt   33887
Mailing Address 3850 ANNAPOLIS LANE NORTH, SUITE 180 PLYMOUTH MN 55447-5476
Business Address 3850 ANNAPOLIS LANE NORTH, SUITE 180 PLYMOUTH MN 55447-5476 612-747-4423
BioAmber Inc. (Filer) CIK: 0001534287 (see all company filings)

IRS No.: 980601045 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35905 | Film No.: 18622046
SIC: 2860 Industrial Organic Chemicals